SBTX — Skinbiotherapeutics Share News
0.000.00%
- £42.05m
- £41.84m
- £1.21m
REG - SkinBioTherapeutics - Conversion Notice and Total Voting Rights
AnnouncementREG - SkinBioTherapeutics - Notice of Results
AnnouncementREG - AIM - AIM Notice - 29/02/2024
AnnouncementREG - SkinBioTherapeutics - Conversion notice and alternative financing
AnnouncementREG - SkinBioTherapeutics - Positive Interim AxisBiotix Acne study results
AnnouncementREG - SkinBioTherapeutics - Dermatonics to launch Once Heel Balm in AMEA
AnnouncementREG - SkinBioTherapeutics - Conversion Notice and Total Voting Rights
AnnouncementREG - SkinBioTherapeutics - Dermatonics Full Year trading update
AnnouncementREG - SkinBioTherapeutics - Completion of Acquisition of Dermatonics
AnnouncementREG - SkinBioTherapeutics - £5.0m Convertible Bond Facility & First Drawdown
AnnouncementREG - SkinBioTherapeutics - Acquisition of Dermatonics
AnnouncementREG - SkinBioTherapeutics - Result of AGM
AnnouncementREG - SkinBioTherapeutics - Update on transaction timelines to early 2024
AnnouncementREG - SkinBioTherapeutics - Notice of AGM and posting of Annual Report
AnnouncementREG - SkinBioTherapeutics - Final Results
AnnouncementREG - SkinBioTherapeutics - AxisBiotix-Ps™ to launch on Amazon UK
AnnouncementREG - SkinBioTherapeutics OptiBiotix Health - Holding(s) in Company
AnnouncementREG - SkinBioTherapeutics - Holding(s) in Company
AnnouncementREG - AIM - AIM Notice - 22/11/2023
Announcement